NO20054144L - Anvendelse av bradykinin-B2-reseptorantagonister for behandling av osteoartrose - Google Patents

Anvendelse av bradykinin-B2-reseptorantagonister for behandling av osteoartrose

Info

Publication number
NO20054144L
NO20054144L NO20054144A NO20054144A NO20054144L NO 20054144 L NO20054144 L NO 20054144L NO 20054144 A NO20054144 A NO 20054144A NO 20054144 A NO20054144 A NO 20054144A NO 20054144 L NO20054144 L NO 20054144L
Authority
NO
Norway
Prior art keywords
bradykinin
diseases
osteoarthrosis
treatment
joint
Prior art date
Application number
NO20054144A
Other languages
English (en)
Other versions
NO333903B1 (no
Inventor
Karl Rudolphi
Martin Michaelis
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20054144L publication Critical patent/NO20054144L/no
Publication of NO333903B1 publication Critical patent/NO333903B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Peptider med bradykinin antagonistiske virking egner seg for fremstilling av legemidler for profilakse og av sykdommer hvis utvikling er forbundet med en forøket aktivitet av matriks-metalkpi.ril hører sykdommer som degenerative leddsykdommer, eksempelvis (N-oon;-trose, spondy.ose saii.L briisksvinn etter leddtraumer eller lengre inaktivitet av ledd etter menisk- eller patellaskader eller håndbrudd.
NO20054144A 2003-02-07 2005-09-06 Anvendelse av bradykinin-B2-reseptorantagonister for produksjon av farmasøytiske midler til bruk i behandling av osteoartrose NO333903B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10304994A DE10304994A1 (de) 2003-02-07 2003-02-07 Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
PCT/EP2004/000550 WO2004069266A2 (de) 2003-02-07 2004-01-23 Die verwendung von antagonisten des bradykinin-b2 rezeptors zur behandlung von osteoarthrose

Publications (2)

Publication Number Publication Date
NO20054144L true NO20054144L (no) 2005-09-06
NO333903B1 NO333903B1 (no) 2013-10-14

Family

ID=32797325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054144A NO333903B1 (no) 2003-02-07 2005-09-06 Anvendelse av bradykinin-B2-reseptorantagonister for produksjon av farmasøytiske midler til bruk i behandling av osteoartrose

Country Status (31)

Country Link
EP (1) EP1594520B1 (no)
JP (1) JP2006516980A (no)
KR (1) KR20050105447A (no)
CN (1) CN1317029C (no)
AR (1) AR043036A1 (no)
AT (1) ATE335500T1 (no)
AU (1) AU2004210396A1 (no)
BR (1) BRPI0407333A (no)
CA (1) CA2514152C (no)
CO (1) CO5690613A2 (no)
CY (1) CY1105708T1 (no)
DE (2) DE10304994A1 (no)
DK (1) DK1594520T3 (no)
ES (1) ES2268622T3 (no)
HK (1) HK1085926A1 (no)
HR (1) HRP20050701B1 (no)
IL (1) IL169899A0 (no)
MA (1) MA27618A1 (no)
ME (1) MEP41008A (no)
MX (1) MXPA05007310A (no)
MY (1) MY135827A (no)
NO (1) NO333903B1 (no)
NZ (1) NZ541680A (no)
PE (1) PE20040939A1 (no)
PL (1) PL206412B1 (no)
PT (1) PT1594520E (no)
RS (1) RS51029B (no)
RU (1) RU2329057C2 (no)
TW (1) TW200505472A (no)
WO (1) WO2004069266A2 (no)
ZA (1) ZA200505177B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710522D0 (en) * 2007-06-01 2007-07-11 Royal Veterinary College The Drug delivery system comprising matrix metalloproteinase inhibitors
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
FR2751650B1 (fr) * 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
CA2364178C (en) * 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
CA2474645C (en) * 2002-02-01 2011-08-09 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation

Also Published As

Publication number Publication date
NO333903B1 (no) 2013-10-14
AR043036A1 (es) 2005-07-13
HK1085926A1 (en) 2006-09-08
BRPI0407333A (pt) 2006-01-10
ZA200505177B (en) 2006-11-29
DE502004001159D1 (de) 2006-09-21
MA27618A1 (fr) 2005-11-01
RS20050565A (en) 2007-09-21
EP1594520A2 (de) 2005-11-16
ES2268622T3 (es) 2007-03-16
CN1747742A (zh) 2006-03-15
ATE335500T1 (de) 2006-09-15
CA2514152C (en) 2012-01-17
PL376605A1 (pl) 2006-01-09
CN1317029C (zh) 2007-05-23
TW200505472A (en) 2005-02-16
IL169899A0 (en) 2011-08-01
PL206412B1 (pl) 2010-08-31
CA2514152A1 (en) 2004-08-19
JP2006516980A (ja) 2006-07-13
AU2004210396A1 (en) 2004-08-19
RU2005127862A (ru) 2006-01-27
DE10304994A1 (de) 2004-09-02
HRP20050701A2 (en) 2006-09-30
HRP20050701B1 (hr) 2014-01-03
DK1594520T3 (da) 2006-12-11
WO2004069266A2 (de) 2004-08-19
MY135827A (en) 2008-07-31
CO5690613A2 (es) 2006-10-31
CY1105708T1 (el) 2010-12-22
MEP41008A (en) 2011-02-10
EP1594520B1 (de) 2006-08-09
WO2004069266A3 (de) 2004-09-30
PT1594520E (pt) 2006-11-30
MXPA05007310A (es) 2005-09-30
RS51029B (sr) 2010-10-31
PE20040939A1 (es) 2005-01-17
RU2329057C2 (ru) 2008-07-20
NZ541680A (en) 2009-07-31
KR20050105447A (ko) 2005-11-04

Similar Documents

Publication Publication Date Title
EP2114925B8 (en) Azetidine analogues of nucleosidase and phosphorylase inhibitors
ZA200705115B (en) Indazole-carboxamide compounds
PA8637601A1 (es) Compuestos moduladores de la actividad de c-kit y usos de los mismos
TNSN07161A1 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
AU2002344951A1 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
WO2005062881A3 (en) Gene therapy using transposon-based vectors
MX2007008614A (es) Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r).
TW200505881A (en) Tri(cyclo) substituted amide compounds
DE602005014566D1 (de) Chinolinon-carboxamid-verbindungen
MY137053A (en) Pyrimidine derivatives and their use as cb2 modulators
EA200601160A1 (ru) 2,6-бисгетероарил-4-аминопиримидины в качестве антагонистов аденозиновых рецепторов
ATE441646T1 (de) 5-ht4-rezeptoragonistenverbindungen
NO341679B1 (no) Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
RS20070077A (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases
NO20054144L (no) Anvendelse av bradykinin-B2-reseptorantagonister for behandling av osteoartrose
AU2003215680A1 (en) New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
ATE325115T1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
ATE329916T1 (de) Azaindolylpiperidinderivate als antihistaminika und antiallergika
UA92463C2 (ru) Производные пиримидинсульфонамида как модуляторы рецепторов хемокина
WO2004087905A3 (en) Protein tyrosine phosphatase and inhibitors thereof
NO20023841L (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemet hos menn
WO2004084800A3 (en) A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
EP1591454A4 (en) NOVEL LYSOPHOSPHACIDIC ACID RECEPTOR

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees